Group effect in 2x2 BE study [Software]

posted by ElMaestro  – Denmark, 2014-06-30 22:36 (4356 d 23:01 ago) – Posting: # 13176
Views: 30,877

Hi Zan,

❝ Thanks very much for the useful reply, ElMaestro and Helmut! Yes I am using Phoenix Winnonlin to work on this analysis. If there is a significant treatment*Group effect, is the overall (all subject) ratio (CI90%) still valid, or we have to adopt the ratio (CI90%) from separate groups?


I personally find it very difficult to address a significant group x treatment interaction. To help visual interpretation you could plot the four effects in a bar diagram. A low p-value for group x treatment means you think the four bars all not of equal height. Where does that leave us?
ABE is all about the treatment performance in itself and not treatment in summer versus treatment in winter (the latter just to make it a little extreme, hope you get the general idea). Sure, if there is a pronounced difference in stability of T and R, respectively, and the two groups are well separated in time then we could observe group x treatment, but this is speculation and besides if such stability differences would exist they should be caught and handled well before any study is kicked off cf. GMP and GCP.
I am inclined to say a significant group x treatment should be considered a mere nuisance just like Conchita Wurst or nail fungus.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
408 visitors (0 registered, 408 guests [including 43 identified bots]).
Forum time: 21:38 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5